Crossmark

<scp>PTPN</scp> 2 phosphatase deletion in T cells promotes anti‐tumour immunity and <scp>CAR</scp> T‐cell efficacy in solid tumours

Crossref DOI link: https://doi.org/10.15252/embj.2019103637

Published Online: 2019-12-05

Published Print: 2020-01-15

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Wiede, Florian https://orcid.org/0000-0001-5145-7180
Lu, Kun‐Hui

Du, Xin

Liang, Shuwei

Hochheiser, Katharina

Dodd, Garron T

Goh, Pei K

Kearney, Conor

Meyran, Deborah

Beavis, Paul A

Henderson, Melissa A

Park, Simone L

Waithman, Jason

Zhang, Sheng

Zhang, Zhong‐Yin

Oliaro, Jane

Gebhardt, Thomas

Darcy, Phillip K

Tiganis, Tony https://orcid.org/0000-0002-8065-9942
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1132373, APP1136680, APP1103037)

National Institutes of Health (RO1 CA207288)

Cancer Council Victoria (1106477)
License Information

Version of Record valid from 2019-12-05
More Information

Publication History

Received: 2019-10-04

Accepted: 2019-11-08

Published: 2019-12-05